Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, an... Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases. Mehr anzeigen
– Presented additional data from the Phase 1 clinical trial ENTR-601-44-101 and new preclinical data supporting ENTR-601-45 for DMD at 2024 World Muscle Society Annual Congress – – On track to...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.78 | -8.953722334 | 19.88 | 20.2499 | 17.09 | 111011 | 18.10416862 | CS |
| 4 | 1.03 | 6.03397773872 | 17.07 | 20.49 | 16.8104 | 132666 | 18.66839731 | CS |
| 12 | 1.6 | 9.69696969697 | 16.5 | 20.49 | 13.46 | 138697 | 16.77396568 | CS |
| 26 | 2.8 | 18.3006535948 | 15.3 | 20.49 | 13.46 | 125584 | 16.40177746 | CS |
| 52 | 1.8 | 11.0429447853 | 16.3 | 20.49 | 10.7501 | 104452 | 15.37705396 | CS |
| 156 | -14.92 | -45.1847365233 | 33.02 | 34.35 | 5.12 | 89577 | 14.56106687 | CS |
| 260 | -8.4 | -31.6981132075 | 26.5 | 36.85 | 5.12 | 93446 | 15.41214207 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
